Beyond A1C—Standardization of Continuous Glucose Monitoring Reporting: Why It Is Needed and How It Continues to Evolve-Reference-Cited by-同舟云学术

Beyond A1C—Standardization of Continuous Glucose Monitoring Reporting: Why It Is Needed and How It Continues to Evolve

Published:2021-05-01 Issue:2 Volume:34 Page:102-108
ISSN:1040-9165
Container-title:Diabetes Spectrum
language:en
Short-container-title:

Author:

Beck Roy W.¹^ORCID,Bergenstal Richard M.²^ORCID

Affiliation:

1. Jaeb Center for Health Research, Tampa, FL

2. International Diabetes Center, HealthPartners Institute, Minneapolis, MN

Abstract

Continuous glucose monitoring (CGM) systems are becoming part of standard care for type 1 diabetes, and their use is increasing for type 2 diabetes. Consensus has been reached on standardized metrics for reporting CGM data, with time in range of 70–180 mg/dL and time below 54 mg/dL recognized as the key metrics of focus for diabetes management. The ambulatory glucose profile report has emerged as the standard for visualization of CGM data and will continue to evolve to incorporate other elements such as insulin, food, and exercise data to support glycemic management.

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/spectrum/article-pdf/34/2/102/507179/diaspectds200090.pdf

Reference50 articles.

1. Optimal sampling duration for continuous glucose monitoring to determine long-term glycemic control;Riddlesworth;Diabetes Technol Ther,2018

2. Glycemic outcomes in adults with T1D are impacted more by continuous glucose monitoring than by insulin delivery method: 3 years of follow-up from the COMISAIR study;Šoupal;Diabetes Care,2020

3. Standardizing clinically meaningful outcome measures beyond HbA1c for type 1 diabetes: a consensus report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, the Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange;Agiostratidou;Diabetes Care,2017

4. Need for regulatory change to incorporate beyond A1C glycemic metrics;Beyond A1C Writing Group;Diabetes Care,2018

5. International consensus on use of continuous glucose monitoring;Danne;Diabetes Care,2017

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Limitations of 14-Day Continuous Glucose Monitoring Sampling for Assessment of Hypoglycemia and Glycemic Variability in Type 1 Diabetes;Diabetes Technology & Therapeutics;2024-07-01

2. Expert Panel Recommendations for a Standardized Ambulatory Glucose Profile Report for Connected Insulin Pens;Diabetes Technology & Therapeutics;2024-06-10

3. Association between continuous glucose monitoring metrics and clinical outcomes in adults with type 1 diabetes in a real-world setting;Diabetes Research and Clinical Practice;2024-06

4. Integrated modeling of labile and glycated hemoglobin with glucose for enhanced diabetes detection and short-term monitoring;iScience;2024-04

5. Decreasing the Burden of Carbohydrate Counting and Meal Announcement with Automated Insulin Delivery, Meal Recognition, and Autocorrection Doses: A Case Study;Diabetes Technology & Therapeutics;2024-03-01